Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2016

01-05-2016 | Original Article

Risk factors for long-term mortality of Staphylococcus aureus bacteremia

Authors: D. Yahav, S. Yassin, H. Shaked, E. Goldberg, J. Bishara, M. Paul, L. Leibovici

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2016

Login to get access

Abstract

Staphylococcus aureus bacteremia (SAB) is a fatal disease. We aimed to describe risk factors for long-term mortality with SAB. We analyzed data from a retrospectively collected database including 1,692 patients with SAB. We considered variables of infection and background conditions for the analysis of long-term survival. The Kaplan–Meier procedure was used for analysis of long-term survival. Variables significantly associated with mortality were analyzed using a Cox regression model. We included 1,692 patients in the analysis. Patients were followed for up to 22 years. Within one year, 62% of patients died and within 5 years 72% died. A total of 82% of patients aged 65 years and older died within 5 years. Independent predictors of long-term mortality were older age (Hazard ratio 1.029, 95% confidence interval 1.022–1.036), female gender (HR 1.302, 95% CI 1.118–1.517), pneumonia or primary/ unknown source of infection (HR 1.441, 95% CI 1.230–1.689), dementia (HR 1.234, 95% CI 1.004–1.516), higher Charlson score (HR 1.155, 95% CI 1.115–1.196), shock at onset (HR 1.776, 95% CI 1.430–2.207) and arrival to hospitalization from an institution (HR 1.319, 95% CI 1.095–1.563). Long-term survival of patients older than 65 years and of women with SAB is severely curtailed.
Literature
2.
go back to reference Khatib R, Sharma M (2013) Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia. Medicine (Baltimore) 92:182–188CrossRef Khatib R, Sharma M (2013) Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia. Medicine (Baltimore) 92:182–188CrossRef
4.
go back to reference Kobayashi D, Yokota K, Takahashi O et al (2014) A predictive rule for mortality of inpatients with Staphylococcus aureus bacteraemia: A classification and regression tree analysis. Eur J Intern Med 25:914–918CrossRefPubMed Kobayashi D, Yokota K, Takahashi O et al (2014) A predictive rule for mortality of inpatients with Staphylococcus aureus bacteraemia: A classification and regression tree analysis. Eur J Intern Med 25:914–918CrossRefPubMed
5.
go back to reference Paulsen J, Mehl A, Askim A et al (2015) Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: an observational study. BMC Infect Dis 15:116CrossRefPubMedPubMedCentral Paulsen J, Mehl A, Askim A et al (2015) Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: an observational study. BMC Infect Dis 15:116CrossRefPubMedPubMedCentral
6.
go back to reference Yaw LK, Robinson JO, Ho KM (2014) A comparison of long-term outcomes after methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 14:967–975 Yaw LK, Robinson JO, Ho KM (2014) A comparison of long-term outcomes after methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 14:967–975
7.
go back to reference Fatkenheuer G, Preuss M, Salzberger B et al (2004) Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 23:157–162CrossRefPubMed Fatkenheuer G, Preuss M, Salzberger B et al (2004) Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 23:157–162CrossRefPubMed
8.
go back to reference Hanses F, Spaeth C, Ehrenstein BP et al (2010) Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection 38:465–470CrossRefPubMed Hanses F, Spaeth C, Ehrenstein BP et al (2010) Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection 38:465–470CrossRefPubMed
10.
go back to reference Paul M, Kariv G, Goldberg E et al (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65:2658–2665CrossRefPubMed Paul M, Kariv G, Goldberg E et al (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65:2658–2665CrossRefPubMed
11.
go back to reference Hidayat LK, Hsu DI, Quist R et al (2006) High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166:2138–2144CrossRefPubMed Hidayat LK, Hsu DI, Quist R et al (2006) High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166:2138–2144CrossRefPubMed
12.
go back to reference Paul M, Zemer-Wassercug N, Talker O et al (2011) Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 17:1581–1586CrossRefPubMed Paul M, Zemer-Wassercug N, Talker O et al (2011) Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 17:1581–1586CrossRefPubMed
13.
go back to reference Haessler S, Mackenzie T, Kirkland KB (2008) Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus. J Hosp Infect 69:39–45CrossRefPubMed Haessler S, Mackenzie T, Kirkland KB (2008) Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus. J Hosp Infect 69:39–45CrossRefPubMed
14.
go back to reference Ho KM, Robinson JO (2009) Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care 37:457–463PubMed Ho KM, Robinson JO (2009) Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care 37:457–463PubMed
15.
go back to reference Lamagni TL, Potz N, Powell D et al (2011) Mortality in patients with methicillin-resistant Staphylococcus aureus bacteraemia, England 2004–2005. J Hosp Infect 77:16–20CrossRefPubMed Lamagni TL, Potz N, Powell D et al (2011) Mortality in patients with methicillin-resistant Staphylococcus aureus bacteraemia, England 2004–2005. J Hosp Infect 77:16–20CrossRefPubMed
16.
go back to reference Maor Y, Hagin M, Belausov N et al (2009) Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 199:619–624CrossRefPubMed Maor Y, Hagin M, Belausov N et al (2009) Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 199:619–624CrossRefPubMed
17.
go back to reference Seybold U, Kourbatova EV, Johnson JG et al (2006) Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 42:647–656CrossRefPubMed Seybold U, Kourbatova EV, Johnson JG et al (2006) Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 42:647–656CrossRefPubMed
18.
go back to reference Allard C, Carignan A, Bergevin M et al (2008) Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991–2005. Clin Microbiol Infect 14:421–428CrossRefPubMed Allard C, Carignan A, Bergevin M et al (2008) Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991–2005. Clin Microbiol Infect 14:421–428CrossRefPubMed
19.
go back to reference Mansur N, Hazzan R, Paul M et al (2012) Does sex affect 30-day mortality in Staphylococcus aureus bacteremia? Gend Med 9:463–470 Mansur N, Hazzan R, Paul M et al (2012) Does sex affect 30-day mortality in Staphylococcus aureus bacteremia? Gend Med 9:463–470
Metadata
Title
Risk factors for long-term mortality of Staphylococcus aureus bacteremia
Authors
D. Yahav
S. Yassin
H. Shaked
E. Goldberg
J. Bishara
M. Paul
L. Leibovici
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2598-8

Other articles of this Issue 5/2016

European Journal of Clinical Microbiology & Infectious Diseases 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine